Douglas Taren
Concepts (397)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutritional Status | 13 | 2026 | 354 | 2.390 |
Why?
| | Agricultural Irrigation | 3 | 2025 | 3 | 2.030 |
Why?
| | Diet | 12 | 2025 | 1273 | 1.870 |
Why?
| | Vitamin A Deficiency | 6 | 2019 | 26 | 1.460 |
Why?
| | Nutritional Sciences | 5 | 2026 | 38 | 1.180 |
Why?
| | Anemia, Iron-Deficiency | 3 | 2019 | 62 | 1.060 |
Why?
| | Ecosystem | 2 | 2023 | 589 | 1.060 |
Why?
| | Solar Energy | 2 | 2019 | 34 | 1.060 |
Why?
| | Malnutrition | 2 | 2026 | 86 | 1.060 |
Why?
| | Child Nutrition Disorders | 1 | 2026 | 20 | 0.940 |
Why?
| | Deoxyglucose | 1 | 2026 | 51 | 0.930 |
Why?
| | Feeding Behavior | 7 | 2026 | 684 | 0.930 |
Why?
| | Forensic Nursing | 1 | 2024 | 2 | 0.860 |
Why?
| | Food Supply | 4 | 2023 | 90 | 0.850 |
Why?
| | Saliva | 1 | 2026 | 249 | 0.820 |
Why?
| | Thinness | 2 | 2026 | 99 | 0.800 |
Why?
| | Acanthosis Nigricans | 1 | 2023 | 4 | 0.800 |
Why?
| | Climate Change | 2 | 2025 | 199 | 0.790 |
Why?
| | Weight Gain | 2 | 2026 | 556 | 0.750 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 84 | 0.740 |
Why?
| | Education, Public Health Professional | 2 | 2015 | 10 | 0.730 |
Why?
| | Hyperglycemia | 1 | 2026 | 375 | 0.710 |
Why?
| | Mobile Applications | 1 | 2024 | 196 | 0.690 |
Why?
| | Resilience, Psychological | 1 | 2023 | 152 | 0.690 |
Why?
| | Sex Offenses | 1 | 2024 | 196 | 0.690 |
Why?
| | Anthropometry | 4 | 2018 | 200 | 0.680 |
Why?
| | Rural Population | 7 | 2026 | 650 | 0.680 |
Why?
| | Benin | 4 | 2025 | 6 | 0.640 |
Why?
| | Premature Birth | 1 | 2023 | 380 | 0.590 |
Why?
| | Vitamin A | 7 | 2019 | 59 | 0.580 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 321 | 0.570 |
Why?
| | Iron | 2 | 2019 | 359 | 0.540 |
Why?
| | Burnout, Professional | 1 | 2024 | 484 | 0.520 |
Why?
| | Lasers | 1 | 2018 | 132 | 0.520 |
Why?
| | Anemia | 4 | 2026 | 188 | 0.510 |
Why?
| | Infant | 13 | 2026 | 10034 | 0.510 |
Why?
| | Crops, Agricultural | 1 | 2016 | 31 | 0.480 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2583 | 0.470 |
Why?
| | Poverty | 2 | 2017 | 529 | 0.460 |
Why?
| | Child, Preschool | 16 | 2026 | 11787 | 0.440 |
Why?
| | Fatigue Syndrome, Chronic | 2 | 2025 | 19 | 0.440 |
Why?
| | Infant, Newborn | 8 | 2026 | 6429 | 0.430 |
Why?
| | Problem-Based Learning | 1 | 2015 | 98 | 0.410 |
Why?
| | Breast Feeding | 3 | 2026 | 448 | 0.410 |
Why?
| | Humans | 66 | 2026 | 144759 | 0.400 |
Why?
| | Public Health | 2 | 2018 | 566 | 0.390 |
Why?
| | Program Evaluation | 4 | 2016 | 948 | 0.380 |
Why?
| | Prevalence | 7 | 2026 | 2834 | 0.380 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2026 | 149 | 0.380 |
Why?
| | Energy Intake | 4 | 2023 | 499 | 0.380 |
Why?
| | Female | 46 | 2026 | 78271 | 0.380 |
Why?
| | Micronutrients | 2 | 2025 | 96 | 0.360 |
Why?
| | Cross-Sectional Studies | 9 | 2026 | 5868 | 0.310 |
Why?
| | Microbiota | 1 | 2017 | 781 | 0.300 |
Why?
| | Male | 31 | 2026 | 72315 | 0.290 |
Why?
| | Maternal-Child Health Centers | 1 | 2008 | 8 | 0.290 |
Why?
| | Uganda | 2 | 2026 | 93 | 0.280 |
Why?
| | Healthcare Disparities | 1 | 2015 | 727 | 0.270 |
Why?
| | Adaptation, Psychological | 2 | 2024 | 717 | 0.270 |
Why?
| | Nutritional Physiological Phenomena | 3 | 2021 | 55 | 0.260 |
Why?
| | Night Blindness | 2 | 2004 | 6 | 0.260 |
Why?
| | Socioeconomic Factors | 6 | 2019 | 1326 | 0.260 |
Why?
| | Zambia | 2 | 2024 | 57 | 0.260 |
Why?
| | Electric Countershock | 9 | 1980 | 127 | 0.250 |
Why?
| | Child | 10 | 2026 | 22633 | 0.250 |
Why?
| | Adult | 24 | 2026 | 40449 | 0.250 |
Why?
| | Milk, Human | 2 | 2026 | 172 | 0.240 |
Why?
| | Prenatal Care | 2 | 2023 | 307 | 0.240 |
Why?
| | Fitness Trackers | 1 | 2025 | 16 | 0.240 |
Why?
| | Universities | 1 | 2008 | 452 | 0.230 |
Why?
| | Gardening | 2 | 2019 | 13 | 0.230 |
Why?
| | Cooperative Behavior | 1 | 2008 | 465 | 0.230 |
Why?
| | Infant Formula | 1 | 2026 | 71 | 0.230 |
Why?
| | Surveys and Questionnaires | 8 | 2020 | 6048 | 0.220 |
Why?
| | Residential Facilities | 1 | 2024 | 8 | 0.220 |
Why?
| | Body Image | 3 | 2008 | 97 | 0.210 |
Why?
| | Kenya | 3 | 2022 | 129 | 0.210 |
Why?
| | Body Mass Index | 6 | 2023 | 2438 | 0.210 |
Why?
| | Hemoglobins | 2 | 2025 | 384 | 0.210 |
Why?
| | Education, Distance | 2 | 2019 | 61 | 0.210 |
Why?
| | Information Dissemination | 1 | 2026 | 223 | 0.200 |
Why?
| | Focus Groups | 2 | 2024 | 573 | 0.200 |
Why?
| | Adolescent | 11 | 2026 | 22428 | 0.200 |
Why?
| | Starch | 1 | 2023 | 22 | 0.200 |
Why?
| | Infectious Disease Transmission, Vertical | 2 | 2022 | 193 | 0.200 |
Why?
| | Sugars | 1 | 2023 | 41 | 0.190 |
Why?
| | Agriculture | 1 | 2023 | 104 | 0.190 |
Why?
| | Eating | 4 | 2011 | 389 | 0.190 |
Why?
| | Dietetics | 1 | 2002 | 24 | 0.190 |
Why?
| | Food Services | 3 | 1991 | 21 | 0.190 |
Why?
| | Dietary Carbohydrates | 1 | 2023 | 151 | 0.180 |
Why?
| | Young Adult | 6 | 2026 | 14105 | 0.180 |
Why?
| | Pregnancy Complications | 2 | 2005 | 592 | 0.180 |
Why?
| | Vegetables | 2 | 2022 | 170 | 0.180 |
Why?
| | Knowledge | 1 | 2022 | 57 | 0.180 |
Why?
| | Food Assistance | 1 | 2022 | 34 | 0.170 |
Why?
| | Self Care | 1 | 2024 | 389 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 488 | 0.170 |
Why?
| | Arizona | 4 | 2015 | 81 | 0.170 |
Why?
| | Exercise | 4 | 2025 | 2201 | 0.170 |
Why?
| | Social Desirability | 2 | 2006 | 13 | 0.170 |
Why?
| | Curriculum | 4 | 2020 | 1059 | 0.170 |
Why?
| | Pregnancy | 8 | 2023 | 7190 | 0.160 |
Why?
| | Internet | 1 | 2026 | 699 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2022 | 249 | 0.160 |
Why?
| | HIV | 1 | 2022 | 250 | 0.160 |
Why?
| | Self-Management | 1 | 2023 | 201 | 0.160 |
Why?
| | Infant, Low Birth Weight | 2 | 1991 | 153 | 0.160 |
Why?
| | Nutrition Disorders | 3 | 2011 | 20 | 0.160 |
Why?
| | Diet Records | 6 | 2006 | 85 | 0.160 |
Why?
| | Birth Weight | 1 | 2023 | 522 | 0.150 |
Why?
| | Cacao | 1 | 1999 | 6 | 0.150 |
Why?
| | Pilot Projects | 3 | 2026 | 1886 | 0.150 |
Why?
| | Mothers | 3 | 2022 | 775 | 0.150 |
Why?
| | Psychopharmacology | 1 | 1999 | 7 | 0.150 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2000 | 98 | 0.150 |
Why?
| | Integrative Medicine | 1 | 2019 | 17 | 0.150 |
Why?
| | Contraceptive Agents | 1 | 2019 | 65 | 0.150 |
Why?
| | Nutrition Assessment | 2 | 2017 | 92 | 0.140 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2000 | 142 | 0.140 |
Why?
| | Behavior, Addictive | 1 | 1999 | 88 | 0.140 |
Why?
| | Contraception Behavior | 1 | 2019 | 107 | 0.140 |
Why?
| | Family Planning Services | 1 | 2019 | 94 | 0.140 |
Why?
| | Nutrition Surveys | 2 | 2017 | 282 | 0.140 |
Why?
| | Education, Medical, Undergraduate | 1 | 2001 | 206 | 0.140 |
Why?
| | Dietary Fats | 1 | 2000 | 314 | 0.130 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 428 | 0.130 |
Why?
| | Nigeria | 3 | 2022 | 24 | 0.130 |
Why?
| | Orosomucoid | 1 | 2017 | 9 | 0.130 |
Why?
| | Middle Aged | 12 | 2025 | 35875 | 0.130 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2017 | 19 | 0.130 |
Why?
| | Observer Variation | 1 | 2018 | 355 | 0.130 |
Why?
| | Self Disclosure | 2 | 2008 | 62 | 0.130 |
Why?
| | Ferritins | 1 | 2017 | 69 | 0.120 |
Why?
| | Feeding and Eating Disorders | 1 | 1999 | 162 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 335 | 0.120 |
Why?
| | Databases, Factual | 1 | 2002 | 1486 | 0.120 |
Why?
| | Retinal Detachment | 2 | 1995 | 72 | 0.120 |
Why?
| | HIV Infections | 2 | 2022 | 3154 | 0.120 |
Why?
| | Smoking Cessation | 2 | 2016 | 439 | 0.120 |
Why?
| | Attitude of Health Personnel | 2 | 2020 | 1185 | 0.120 |
Why?
| | Bupropion | 1 | 2016 | 46 | 0.110 |
Why?
| | Intestinal Diseases, Parasitic | 3 | 1992 | 12 | 0.110 |
Why?
| | Schools, Public Health | 1 | 2015 | 4 | 0.110 |
Why?
| | Pregnancy Complications, Hematologic | 2 | 2012 | 24 | 0.110 |
Why?
| | Poverty Areas | 1 | 2015 | 42 | 0.110 |
Why?
| | Scleral Buckling | 2 | 1995 | 16 | 0.110 |
Why?
| | Education, Graduate | 1 | 2015 | 36 | 0.110 |
Why?
| | Urban Health | 1 | 2015 | 96 | 0.110 |
Why?
| | Hospitals, Rural | 1 | 2015 | 51 | 0.110 |
Why?
| | Reproducibility of Results | 5 | 2018 | 3409 | 0.110 |
Why?
| | C-Reactive Protein | 1 | 2017 | 416 | 0.110 |
Why?
| | Social Justice | 1 | 2015 | 86 | 0.100 |
Why?
| | Stress, Physiological | 1 | 2017 | 453 | 0.100 |
Why?
| | Logistic Models | 2 | 2017 | 2117 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2017 | 321 | 0.100 |
Why?
| | Ascariasis | 3 | 1988 | 3 | 0.100 |
Why?
| | Metabolic Syndrome | 1 | 2017 | 354 | 0.100 |
Why?
| | Tobacco Use Disorder | 1 | 2016 | 218 | 0.100 |
Why?
| | Growth | 1 | 1993 | 49 | 0.100 |
Why?
| | Health Personnel | 1 | 2020 | 748 | 0.100 |
Why?
| | Food, Fortified | 1 | 2013 | 44 | 0.100 |
Why?
| | Vision Tests | 2 | 2004 | 22 | 0.100 |
Why?
| | Neurotoxins | 1 | 2012 | 28 | 0.100 |
Why?
| | Sodium Glutamate | 1 | 2012 | 12 | 0.100 |
Why?
| | Program Development | 1 | 2015 | 370 | 0.090 |
Why?
| | Irritable Bowel Syndrome | 1 | 2012 | 29 | 0.090 |
Why?
| | Indians, Central American | 1 | 1992 | 6 | 0.090 |
Why?
| | Primary Health Care | 2 | 2022 | 1733 | 0.090 |
Why?
| | Delivery of Health Care | 1 | 2019 | 947 | 0.090 |
Why?
| | Fibromyalgia | 1 | 2012 | 51 | 0.090 |
Why?
| | Nepal | 3 | 2012 | 32 | 0.090 |
Why?
| | India | 2 | 2023 | 218 | 0.090 |
Why?
| | Neural Tube Defects | 1 | 2013 | 65 | 0.090 |
Why?
| | Self Concept | 2 | 2008 | 253 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1813 | 0.090 |
Why?
| | Folic Acid | 1 | 2013 | 199 | 0.090 |
Why?
| | Depression | 2 | 2006 | 1558 | 0.090 |
Why?
| | Electrodes | 4 | 1979 | 114 | 0.090 |
Why?
| | Obstetric Labor, Premature | 1 | 1991 | 39 | 0.080 |
Why?
| | Risk Factors | 7 | 2017 | 10779 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1414 | 0.080 |
Why?
| | Glutamic Acid | 1 | 2012 | 251 | 0.080 |
Why?
| | Cooking | 1 | 2011 | 67 | 0.080 |
Why?
| | Carotenoids | 3 | 2001 | 48 | 0.080 |
Why?
| | Neoplasms | 1 | 2026 | 2875 | 0.080 |
Why?
| | Xerophthalmia | 2 | 2004 | 7 | 0.080 |
Why?
| | Obesity | 2 | 2017 | 3077 | 0.080 |
Why?
| | Health Promotion | 2 | 2011 | 774 | 0.080 |
Why?
| | Drug Therapy | 1 | 1990 | 80 | 0.080 |
Why?
| | Northwestern United States | 1 | 2008 | 58 | 0.070 |
Why?
| | Southwestern United States | 1 | 2008 | 95 | 0.070 |
Why?
| | Education, Continuing | 1 | 2008 | 41 | 0.070 |
Why?
| | Electrodes, Implanted | 2 | 1978 | 115 | 0.070 |
Why?
| | Pain | 1 | 2012 | 779 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2023 | 1095 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2947 | 0.060 |
Why?
| | Premedication | 1 | 1987 | 42 | 0.060 |
Why?
| | Vitamin E | 1 | 1987 | 121 | 0.060 |
Why?
| | Energy Metabolism | 3 | 2001 | 935 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 1991 | 780 | 0.060 |
Why?
| | Retinol-Binding Proteins | 1 | 2005 | 17 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2005 | 115 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2168 | 0.060 |
Why?
| | Europe | 1 | 2026 | 412 | 0.060 |
Why?
| | Electric Conductivity | 3 | 1979 | 84 | 0.060 |
Why?
| | Wearable Electronic Devices | 1 | 2025 | 63 | 0.050 |
Why?
| | Cardiac Catheterization | 2 | 1978 | 560 | 0.050 |
Why?
| | Feces | 4 | 2012 | 513 | 0.050 |
Why?
| | Animals | 13 | 2017 | 38058 | 0.050 |
Why?
| | Aged | 5 | 2025 | 25913 | 0.050 |
Why?
| | Cryosurgery | 2 | 1995 | 47 | 0.050 |
Why?
| | Wound Healing | 1 | 1987 | 351 | 0.050 |
Why?
| | Vitamin D Deficiency | 1 | 2005 | 186 | 0.050 |
Why?
| | Panama | 4 | 1992 | 14 | 0.050 |
Why?
| | Urban Population | 2 | 2004 | 491 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2023 | 133 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2023 | 312 | 0.050 |
Why?
| | Muscle Fatigue | 1 | 2023 | 97 | 0.050 |
Why?
| | Educational Status | 2 | 2008 | 467 | 0.050 |
Why?
| | Reference Standards | 1 | 2002 | 177 | 0.050 |
Why?
| | Gels | 2 | 1979 | 84 | 0.050 |
Why?
| | Dogs | 7 | 1980 | 437 | 0.050 |
Why?
| | Prospective Studies | 2 | 2025 | 7990 | 0.040 |
Why?
| | Food Preferences | 2 | 2000 | 126 | 0.040 |
Why?
| | Deuterium | 1 | 2001 | 100 | 0.040 |
Why?
| | Plant Oils | 1 | 2001 | 31 | 0.040 |
Why?
| | South Africa | 1 | 2022 | 261 | 0.040 |
Why?
| | Substance-Related Disorders | 1 | 1990 | 1094 | 0.040 |
Why?
| | Time Factors | 6 | 2012 | 7173 | 0.040 |
Why?
| | Public Sector | 1 | 2000 | 17 | 0.040 |
Why?
| | Plethysmography, Impedance | 1 | 1980 | 4 | 0.040 |
Why?
| | Cardiography, Impedance | 1 | 1980 | 9 | 0.040 |
Why?
| | Occupational Health Services | 1 | 2000 | 37 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 1994 | 1539 | 0.040 |
Why?
| | Biogenic Amines | 1 | 1999 | 4 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2000 | 48 | 0.040 |
Why?
| | Xanthines | 1 | 1999 | 22 | 0.040 |
Why?
| | Self Medication | 1 | 1999 | 12 | 0.040 |
Why?
| | Ghana | 1 | 2019 | 43 | 0.040 |
Why?
| | Food Analysis | 1 | 1999 | 24 | 0.040 |
Why?
| | Psychological Techniques | 1 | 1999 | 8 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2001 | 111 | 0.040 |
Why?
| | Lactation | 1 | 2001 | 192 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 2029 | 0.040 |
Why?
| | Respiration | 1 | 1980 | 206 | 0.040 |
Why?
| | Social Responsibility | 1 | 2019 | 55 | 0.040 |
Why?
| | Thorax | 1 | 1979 | 50 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 1999 | 140 | 0.040 |
Why?
| | Schools, Medical | 1 | 2000 | 156 | 0.040 |
Why?
| | Encephalitozoon | 1 | 1998 | 2 | 0.040 |
Why?
| | Encephalitozoonosis | 1 | 1998 | 2 | 0.040 |
Why?
| | Bias | 1 | 1999 | 202 | 0.030 |
Why?
| | Water | 1 | 2001 | 469 | 0.030 |
Why?
| | Cholesterol | 1 | 2000 | 406 | 0.030 |
Why?
| | Ointments | 1 | 1977 | 25 | 0.030 |
Why?
| | Nicotine | 1 | 2000 | 331 | 0.030 |
Why?
| | Peer Group | 1 | 2000 | 257 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2020 | 281 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1720 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2004 | 3604 | 0.030 |
Why?
| | Quality of Life | 2 | 2023 | 3185 | 0.030 |
Why?
| | Education, Medical | 1 | 2000 | 274 | 0.030 |
Why?
| | Cell Membrane | 1 | 2000 | 706 | 0.030 |
Why?
| | Odds Ratio | 2 | 2000 | 1075 | 0.030 |
Why?
| | Placebos | 1 | 2016 | 192 | 0.030 |
Why?
| | Hookworm Infections | 2 | 2012 | 3 | 0.030 |
Why?
| | Diarrhea, Infantile | 1 | 1994 | 4 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 2115 | 0.030 |
Why?
| | Smoking Prevention | 1 | 2016 | 166 | 0.030 |
Why?
| | Cryptosporidium parvum | 1 | 1994 | 13 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 1997 | 259 | 0.030 |
Why?
| | Quality Improvement | 1 | 2023 | 1289 | 0.030 |
Why?
| | Cryptosporidiosis | 1 | 1994 | 22 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2019 | 544 | 0.030 |
Why?
| | Visual Acuity | 2 | 1995 | 489 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 166 | 0.020 |
Why?
| | Laser Therapy | 1 | 1995 | 135 | 0.020 |
Why?
| | Diarrhea | 1 | 1994 | 192 | 0.020 |
Why?
| | China | 1 | 1993 | 269 | 0.020 |
Why?
| | Oregon | 1 | 2012 | 76 | 0.020 |
Why?
| | Latin America | 1 | 2013 | 94 | 0.020 |
Why?
| | Live Birth | 1 | 2013 | 68 | 0.020 |
Why?
| | Body Height | 1 | 1993 | 202 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2012 | 37 | 0.020 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2012 | 9 | 0.020 |
Why?
| | Cultural Characteristics | 1 | 1992 | 70 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 1985 | 0.020 |
Why?
| | Ferrous Compounds | 1 | 1991 | 25 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2027 | 0.020 |
Why?
| | Micronesia | 1 | 2011 | 7 | 0.020 |
Why?
| | Florida | 1 | 1991 | 117 | 0.020 |
Why?
| | Parity | 1 | 1991 | 109 | 0.020 |
Why?
| | Ventricular Fibrillation | 3 | 1980 | 64 | 0.020 |
Why?
| | Nutritional Requirements | 1 | 2011 | 76 | 0.020 |
Why?
| | Overweight | 1 | 2016 | 609 | 0.020 |
Why?
| | Body Weight | 2 | 1993 | 976 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2012 | 601 | 0.020 |
Why?
| | Pain Measurement | 1 | 2012 | 552 | 0.020 |
Why?
| | United States | 2 | 2026 | 15966 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 518 | 0.020 |
Why?
| | Vitamins | 1 | 1991 | 178 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2012 | 441 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2011 | 226 | 0.020 |
Why?
| | Drug Interactions | 1 | 1990 | 398 | 0.020 |
Why?
| | Health Services Research | 1 | 1991 | 396 | 0.020 |
Why?
| | Public Assistance | 1 | 1988 | 19 | 0.020 |
Why?
| | Smoking | 1 | 2016 | 1472 | 0.020 |
Why?
| | Pediatric Obesity | 1 | 2016 | 637 | 0.020 |
Why?
| | Lactose | 1 | 1987 | 7 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2012 | 11679 | 0.020 |
Why?
| | Gastrointestinal Transit | 1 | 1987 | 6 | 0.020 |
Why?
| | Digestion | 1 | 1987 | 10 | 0.020 |
Why?
| | Residence Characteristics | 1 | 1991 | 377 | 0.020 |
Why?
| | Statistics as Topic | 2 | 2001 | 284 | 0.020 |
Why?
| | Hematocrit | 1 | 1987 | 108 | 0.020 |
Why?
| | Breath Tests | 1 | 1987 | 79 | 0.020 |
Why?
| | Hydrogen | 1 | 1987 | 73 | 0.020 |
Why?
| | Diet, Reducing | 1 | 2008 | 91 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 485 | 0.020 |
Why?
| | Hydroxyproline | 1 | 1987 | 18 | 0.020 |
Why?
| | Mass Screening | 2 | 1997 | 1347 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 321 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 836 | 0.020 |
Why?
| | Personality Assessment | 1 | 2006 | 79 | 0.010 |
Why?
| | Mexico | 2 | 1998 | 233 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 2 | 1998 | 370 | 0.010 |
Why?
| | Developing Countries | 1 | 1988 | 318 | 0.010 |
Why?
| | Calcium | 1 | 1991 | 1183 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2925 | 0.010 |
Why?
| | Collagen | 1 | 1987 | 456 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1994 | 5408 | 0.010 |
Why?
| | Mental Recall | 1 | 2006 | 222 | 0.010 |
Why?
| | Surgical Procedures, Operative | 1 | 1987 | 270 | 0.010 |
Why?
| | Blood Proteins | 1 | 2005 | 249 | 0.010 |
Why?
| | Social Support | 1 | 2008 | 652 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 1003 | 0.010 |
Why?
| | Sex Factors | 2 | 2000 | 2112 | 0.010 |
Why?
| | Calorimetry | 1 | 2001 | 72 | 0.010 |
Why?
| | Basal Metabolism | 1 | 2001 | 62 | 0.010 |
Why?
| | Palm Oil | 1 | 2001 | 3 | 0.010 |
Why?
| | beta Carotene | 1 | 2001 | 20 | 0.010 |
Why?
| | Honduras | 1 | 2001 | 16 | 0.010 |
Why?
| | Lutein | 1 | 2001 | 16 | 0.010 |
Why?
| | Administration, Cutaneous | 1 | 2000 | 125 | 0.010 |
Why?
| | Energy Transfer | 1 | 1980 | 49 | 0.010 |
Why?
| | Skin Physiological Phenomena | 1 | 1979 | 24 | 0.010 |
Why?
| | Research Support as Topic | 1 | 2000 | 80 | 0.010 |
Why?
| | Fruit | 1 | 2000 | 152 | 0.010 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2000 | 140 | 0.010 |
Why?
| | Life Style | 1 | 2001 | 479 | 0.010 |
Why?
| | Electronics, Medical | 1 | 1978 | 7 | 0.010 |
Why?
| | Rats | 1 | 1987 | 5597 | 0.010 |
Why?
| | Surface Properties | 1 | 1979 | 410 | 0.010 |
Why?
| | Social Behavior | 1 | 2000 | 288 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1977 | 79 | 0.010 |
Why?
| | Body Composition | 1 | 2001 | 706 | 0.010 |
Why?
| | Water Supply | 1 | 1998 | 88 | 0.010 |
Why?
| | Antioxidants | 1 | 2001 | 549 | 0.010 |
Why?
| | Calcium, Dietary | 1 | 1997 | 53 | 0.010 |
Why?
| | Retrospective Studies | 2 | 1995 | 17066 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 2001 | 8265 | 0.010 |
Why?
| | Dietary Fiber | 1 | 1997 | 59 | 0.010 |
Why?
| | Eligibility Determination | 1 | 1997 | 68 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2001 | 576 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1980 | 338 | 0.010 |
Why?
| | Coronary Disease | 1 | 1978 | 383 | 0.010 |
Why?
| | Colonic Polyps | 1 | 1997 | 85 | 0.010 |
Why?
| | Heart Arrest | 1 | 1980 | 407 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1977 | 361 | 0.010 |
Why?
| | Risk | 1 | 1997 | 911 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 365 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 719 | 0.010 |
Why?
| | Reoperation | 1 | 1995 | 630 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1998 | 1519 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1997 | 1137 | 0.000 |
Why?
| | Models, Biological | 1 | 1977 | 1821 | 0.000 |
Why?
| | New York City | 1 | 1988 | 89 | 0.000 |
Why?
| | New York | 1 | 1988 | 125 | 0.000 |
Why?
| | Entamoebiasis | 1 | 1988 | 1 | 0.000 |
Why?
| | Trichuriasis | 1 | 1988 | 4 | 0.000 |
Why?
| | Ascaris | 1 | 1987 | 2 | 0.000 |
Why?
| | Parasite Egg Count | 1 | 1987 | 5 | 0.000 |
Why?
| | Giardiasis | 1 | 1988 | 21 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2879 | 0.000 |
Why?
| | Electrocardiography | 2 | 1980 | 662 | 0.000 |
Why?
| | Cohort Studies | 1 | 1997 | 5960 | 0.000 |
Why?
| | Seasons | 1 | 1988 | 556 | 0.000 |
Why?
| | Heart Massage | 1 | 1980 | 11 | 0.000 |
Why?
| | Heart Block | 1 | 1980 | 40 | 0.000 |
Why?
| | Epinephrine | 1 | 1980 | 155 | 0.000 |
Why?
| | Necrosis | 1 | 1980 | 244 | 0.000 |
Why?
| | Resuscitation | 1 | 1980 | 302 | 0.000 |
Why?
| | Respiration, Artificial | 1 | 1980 | 708 | 0.000 |
Why?
| | Myocardium | 1 | 1980 | 939 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1980 | 4557 | 0.000 |
Why?
|
|
Taren's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|